Last week (July 18-July 24), a total of 13 companies in Shanghai and Shenzhen stock markets were first released, all of which were approved, including 3 on the main board, 21 on the on the Science and Technology Innovation Board, 8 on the GEM, and 1 on the Beijing Stock Exchange.
According to statistics from the Red Star Capital Bureau, as of last week, 234 companies in Shanghai and Shenzhen have successfully passed the initial public offering in 2022, 16 companies have rejected the conference, 6 companies have been suspended, and the IPO pass rate has risen to 91.41%; a total of 28 companies in the Beijing Stock Exchange have successfully passed the initial public offering, 7 companies have been suspended, and the IPO pass rate has risen to 80%.
At the same time, a total of 10 companies received IPO approvals last week, including 2 on the main board, 4 on the Science and Technology Innovation Board, and 4 on the ChiNext board; but 6 companies also terminated the review, including 2 on the Science and Technology Innovation Board, 3 on the ChiNext board, and 1 on the Beijing Stock Exchange. Last week, the China Securities Regulatory Commission and the three major exchanges did not accept the company's initial public offering applications.
Last Friday (July 22), the Science and Technology Innovation Board celebrated its third anniversary of its opening. As of the close of July 21, 437 companies have been listed on the Science and Technology Innovation Board, with a total market value of 5.56 trillion yuan; if Guobo Electronics and Longda Co., Ltd. were included on July 22, there were 439 listed companies on the Science and Technology Innovation Board. According to Tonghuashun data, except for the Guandian Defense transferred from the Beijing Stock Exchange, the remaining 438 companies actually raised 639.786 billion yuan in IPOs on the Science and Technology Innovation Board; except for the two companies listed on July 22, the remaining 437 companies' closing prices as of July 21 were 122.04% compared with the issue price. In terms of reserve, as of the close of July 22, the official website of , Shanghai Stock Exchange, , showed that there were 122 companies waiting for IPOs on the Science and Technology Innovation Board, of which 33 have been accepted, 83 have been inquired, 2 have been suspended, and 4 have been suspended.
This week (July 25-July 31), 13 companies will be listed on the Shanghai and Shenzhen Stock Exchanges and the Beijing Stock Exchange for the first time, and 11 new stocks will be purchased.
(I)
13 companies were first released last week and passed the meeting
Zhiou Technology, Feiwo Technology and other performance declined.
Last week, a total of 13 companies in the Shanghai and Shenzhen stock markets and the Beijing Stock Exchange were approved for the first launch meeting, including 3 on the main board, 1 on the Science and Technology Innovation Board, 8 on the ChiNext, and 1 on the Beijing Stock Exchange. CICC participated in 3 of them. In terms of
motherboard, Hongshi Laser, Sanboshuo and Jiangshun Precision all passed the review successfully.
Hongshi Laser is a leading supplier of laser cutting equipment in China. It plans to raise 1.209 billion yuan, and the sponsor is CITIC Securities . During the on-site inquiry, the Issuance and Audit Committee mainly asked questions about the three aspects of Hongshi Laser's performance growth, gross profit margin and core technology, and required to explain the reasons and rationality of the significant increase in operating income and net profit during the reporting period, and whether there is a risk of performance decline after listing. The top five customers are mainly financial leasing companies; explain the reasons and rationality of the gross profit margin of the main business in each period in the reporting period is higher than the average value of comparable companies in the same industry, the reasons and rationality of the gross profit margin of various products fluctuating greatly, the reasons and rationality of the gross profit margin of export is higher than the gross profit margin of domestic sales; explain the source of the core patent technology, whether there are problems such as the authorization or license of the main core technology.
Sanboshuo focuses on the research and development, design, production and sales of leisure sports and fitness equipment series products. It plans to raise 1.063 billion yuan, and the sponsor is CICC. During the on-site inquiry, the Issuance and Listing Committee mainly asked questions about the three aspects of Sanboshuo's sales data, labor dispatch, and equity holding, and required explanations on the reasons and rationality of the significant increase in export revenue during the reporting period, and the specific reasons for the decline in performance in the first half of 2022; explain whether the number of labor dispatch personnel in 2019 is a high proportion of whether the "Interim Provisions on Labor Dispatch " seriously violates Article 4 of the "Interim Provisions on Labor Dispatch " and whether there are situations of evading relevant obligations through labor dispatch; explain whether the actual controller Zhu Xilong holds the company's equity on behalf of Lu Moumou, and whether the company's determination of the actual controller is in line with the actual situation of the company.
Jiangshun Precision is mainly engaged in the research, development, design, production and sales of aluminum profile extrusion molds and accessories, aluminum profile extrusion supporting equipment, precision mechanical parts and other products. It plans to raise 560 million yuan, and the sponsor is Huatai United Securities .During the on-site inquiry, the Issuance and Listing Committee mainly asked Jiangshun Precision about the three aspects of gross profit margin, export revenue, and related transactions , requiring explanation of the reasons and rationality of the comprehensive gross profit margin higher than the average of comparable companies in the same industry, the reasons and rationality of the gross profit margin higher than the domestic sales gross profit margin; the reasons for the large fluctuation of overseas sales revenue, the situation and reasons for the addition and withdrawal of the top five customers; explaining the necessity of selling or purchasing to related parties during the reporting period, and whether there is any situation of transferring interests of related parties. In terms of the Science and Technology Innovation Board, only one company, Haochen Software, passed the review last week.
Haochen Software is a leading domestic R&D and design industrial software provider, mainly engaged in the research, development, promotion and sales of CAD-related software. It plans to raise 747 million yuan, and its sponsor is CICC. During the on-site inquiry, the Listing Committee mainly asked Haochen Software about its development prospects, requiring that the company's cloud-based business-related information disclosure accuracy and future plans be explained in combination with core technologies, especially the development trend of 3D technology; and further explain whether the development trend of the Internet advertising business will cause major changes in the company's business structure. In terms of the GEM, a total of eight companies, including Zhiou Technology, Meilixin Technology, Renxin New Materials, Zhongke Magnetics, Cathay Environmental Protection, Feiwo Technology, Haojiang Intelligence, and Xinhongye, have all successfully passed the review.
Zhiou Technology is a world-renowned Internet home brand, and its products mainly include furniture series, home series, courtyard series, pet series and other categories. It plans to raise 1.486 billion yuan, and the sponsor is GF Securities . During the on-site inquiry, the Listing Committee mainly asked Zhiou Technology for performance data and R&D expenses, asking to explain whether the adverse factors that led to the decline in performance since 2021 were eliminated and whether it had a significant adverse impact on the company's sustainable operating capabilities; indicating whether the company has advantages in R&D and innovation, and whether it is in line with the positioning of the GEM. (For details, please click: "Zhiou Technology's annual purchase of furniture sold overseas is 4 billion, and it depends on Amazon's face" )
Merrison is mainly engaged in the research, development, production and sales of aluminum alloy precision die castings in the communications and automobile fields. It plans to raise 820 million yuan, and the sponsor is Changjiang Securities . During the on-site inquiry, the Listing Committee mainly asked Melisson on two aspects: raw material prices and actual controller identification. The application materials show that Yu Kefei and Yu Yajun's brother Yu Renlin indirectly hold 7.81% of the company's shares through the controlling shareholder and serve as a director of the company. The Listing Committee requested to explain the reasons and rationality of not deeming Yu Renlin as the actual controller. After the review, Mercedes-Free will also need to further disclose the effectiveness and sustainability of the raw material price linkage mechanism formed with major customers in its prospectus.
Renxin New Materials' main business is the production and sales of polystyrene polymer materials. It plans to raise 629 million yuan, and its sponsor is Wanhe Securities. During the on-site inquiries, the Listing Committee mainly asked Renxin New Materials about business independence and raw material supply. The declaration materials show that during the reporting period, some customers and suppliers overlapped between the company and other enterprises controlled by the actual controller. The Listing Committee requires explanation of the measures taken to maintain independence with other enterprises controlled by the actual controller and their effectiveness. After the review, Renxin New Materials needs to further explain whether the company has a risk of a continuous decline in operating performance and whether the relevant risk warnings are sufficient; if the procurement of raw materials from China Overseas Shell Petrochemical Co., Ltd. is unable to make specific impact on operating performance.
Zhongke Magnetics is mainly engaged in the research, development, production and sales of permanent magnet materials. It plans to raise 366 million yuan, and the sponsor is Tianfeng Securities . During the on-site inquiry, the Listing Committee mainly asked Zhongke Magnetics about product pricing, settlement methods, etc. The application materials show that Zhongke Magnetics' operating income in 2021 increased by by 244.25% year-on-year, and the net cash flow generated by operating activities was negative. The Listing Committee required that the settlement method for the payment of goods in 2021 have undergone major changes compared with previous years and its impact on the company's operations.After the review, Zhongke Magnetics will further explain the effectiveness of the company's product price transmission mechanism and its impact on future operating performance based on the changes in raw material prices and gross profit margins during the reporting period and product price adjustment policies.
Cathay Environmental Protection’s main business is sludge treatment services, and extends to the fields of complete equipment sales and water environment ecological restoration. It plans to raise 330 million yuan, and the sponsor is Guosen Securities . The declaration materials show that during the reporting period, the sludge treatment business was the main source of profit for Cathay Environmental Protection, and the gross profit margin was higher than that of comparable companies in the same industry. The Listing Committee requested further explanation of the rationality and sustainability of the company maintaining a high gross profit margin during the on-site inquiry. (For details, please click: "Cathay Environmental Protection Transfers to the GEM, I have been honest and sincere in the hard technology attributes not outstanding enough" )
Feiwo Technology specializes in the research and development, manufacturing of high-strength fasteners and provides customers with overall fastening system solutions. It plans to raise 557 million yuan, and the sponsor is Minsheng Securities . During the on-site inquiry, the Listing Committee mainly raised the issue with Feiwo Technology on three aspects: operating performance, cost, and employee shareholding, and required to explain whether the company's operating performance will further decline after the year-on-year decline in operating income, net profit and gross profit margin in 2021; explaining the reasons and rationality that the unit direct material cost of the company's anchor bolt assembly product unit changes in the procurement cost of alloy structural steel. After the meeting, Feiwo Technology needs to add to whether the holdings of 28 financial investors in Changdefuwo and Changdeyuanwo meet relevant regulatory requirements, and disclose them in the prospectus.
Haojiang Intelligent is a smart home industry enterprise, with its main products as intelligent linear drive systems. It plans to raise 661 million yuan, and the sponsor is Credit Suisse Founder Securities . The application materials show that during the reporting period, Haojiang Intelligent third-party collection increased significantly. The Listing Committee required explanation of the reasons and rationality in the on-site inquiry, and the establishment and improvement of the relevant internal control system . After the review, Haojiang Intelligent also needs to disclose the relevant agreements on fee payment, recourse and other rights in the prospectus in the third-party payment agreement. (Please click on the details: "Haojiang Intelligent Disclosure Integrity is Questionable, Last year's net profit and gross profit margin double reduction " )
Xinhongye's main business is the research and development, production and sales of special cables such as photovoltaic cables, new energy vehicle cables, industrial cables, etc. It plans to raise 446 million yuan, and its sponsor is CICC. The application materials show that the gross profit margin of Xinhongye's main products during the reporting period was generally on a downward trend. During the on-site inquiry, the Listing Committee required that the market environment and competitive landscape of photovoltaic and new energy vehicles be combined to explain whether there is a risk of further decline in the gross profit margin of the company's main products. In terms of the
, Liandi Information was approved for the second visit.
Liandi Information is a comprehensive software development and information technology service provider. It plans to raise 208 million yuan, and its sponsor is Dongxing Securities. Its first meeting was held on June 8 this year, and Liandi Information was suspended from deliberation. During the on-site inquiry at the second meeting, the Listing Committee asked Liandi information to explain as of now whether the Jin Industry and Trade and shareholder Ma Xiangyang repayed as promised and the specific repayment situation, and whether the source of Ma Xiangyang's planned repayment of the loan is different from the source of actual repayment.
(II)
6 companies terminated their review and registered
GEM has terminated their review this month 12 companies terminated their review
Last week, a total of 6 companies terminated their IPO review, including 2 on the Science and Technology Innovation Board, 3 on the GEM, and 1 on the Beijing Stock Exchange. CICC participated in two of them.
Science and Technology Innovation Board, Minshi Group and Yunzhou Intelligent 2 companies withdrew their application materials. In addition to the previous Chuanshen Yulian, three companies have terminated the IPO review of the Science and Technology Innovation Board since July.
Among them, Minshi Group (00425.HK) was terminated due to its and its sponsor withdrawing its issuance and listing application.
prospectus shows that Minshi Group is a world-renowned supplier of automotive parts, has formed a product system for various exterior parts and body structural parts, and has developed new electrified and intelligent product lines such as aluminum power battery boxes and smart front faces. From 2018 to 2020, the company's operating income was RMB 12.842 billion, RMB 13.444 billion, and RMB 12.721 billion, respectively, and the net profit attributable to shareholders was RMB 1.687 billion, RMB 1.691 billion and RMB 1.331 billion, respectively.It originally planned to raise 6.5 billion yuan, and its sponsor was Huatai United Securities.
Before this termination, Minshi Group also completed the first round of inquiries and updated its financial data for 2021. Eight major issues such as technological advancement, R&D capabilities, actual controllers, and information disclosure are the key points of the company's inquiry. The Shanghai Stock Exchange requires Minshi Group to explain the core technology and its advanced nature, whether the proportion of R&D personnel is accurate, and the level among companies in the same industry at home and abroad.
Minshi Group replied that compared with comparable companies in the same industry at home and abroad, the proportion of R&D personnel in the company is lower than that of some domestic peers. The main reason is that compared with domestic peers, the company has a large scale, a large employee base, and a large number of employees undertake production and manufacturing functions.
In addition, a legal judgment issue involving the actual controller of the company has also been focused on the review. In November 2019, the High Court of the Hong Kong Special Administrative Region made a judgment on the actual controller of the company Qin Ronghua due to the 2008 related transaction incident and issued a six-year disqualification order. Without the permission of the court, it shall not serve as or remain as a director, liquidator, receiver or property or business manager of any listed or non-listed company in Hong Kong, including the company, its subsidiaries and affiliates; it shall not involve or participate in the management of any listed or non-listed company in Hong Kong, including the company, its subsidiaries and affiliates in any form, whether directly or indirectly, whether involved or participate in the management of any listed or non-listed company in Hong Kong, including the company, its subsidiaries and affiliates.
It is reported that Qin Ronghua served as the company's executive director and CEO from October 2019. Starting from October 2019, Qin Ronghua resigned from all positions in the company and no longer held any position within the period of cancellation. The company's current executive director and chairman is Wei Qinglian (the spouse of Qin Ronghua). In October 2019, Zhao Feng, the company's former executive director, also no longer served as the company's executive director due to the disqualification order of the Hong Kong Special Administrative Region High Court; in May 2020, Huang Qionghui no longer served as the company's executive director, chairman of the board of directors and authorized representative. In March 2019, the company's former chief financial officer Song Xiangling resigned.
In this regard, the Shanghai Stock Exchange asked Minshi Group to explain the way Qin Ronghua controls the company, the nomination and appointment process of resigning executive directors, senior executives and their replacement candidates, whether there is a direct or indirect relationship with Qin Ronghua, and whether such personnel changes have a significant adverse impact on the company's production and operation. In terms of the GEM, Tubatu , Hongren Biology and Cologne New Energy, three companies, withdrawing their application materials. Since July, 12 companies have terminated the GEM IPO review.
Among them, Tubatu and its sponsor withdrew their application for issuance and listing, and the IPO of the GEM was terminated. And this is not the first time Tubatu's IPO failed. As early as 2018, Tubatu submitted a listing application to the Hong Kong Stock Exchange, but failed to enter the Hong Kong Stock Exchange for various reasons.
prospectus shows that Tubatu is a one-stop Internet home decoration platform. From 2019 to 2021, Tubatu's operating income was RMB 680 million, RMB 615 million and RMB 655 million, respectively, and the net profit attributable to shareholders was RMB 79.8213 million, RMB 86.6369 million and RMB 70.3273 million, respectively. It originally planned to raise 704 million yuan, and its sponsor was CICC.
Red Star Capital Bureau noticed that online platform business is the main source of Tubatu's revenue. During the reporting period, its online platform revenue was RMB 655 million, RMB 615 million and RMB 654 million, respectively, accounting for 96.34%, 99.94% and 99.88% of the total revenue respectively; at the same time, among Tubatu's operating costs and operating expenses, sales expenses were very prominent, and sales expenses reached RMB 394 million, RMB 345 million and RMB 400 million respectively during the reporting period. (For details, please click: "Tubatu restarted its listing, self-operated home improvement business has been terminated, and 30% of its revenue has been bought for traffic" )
As an early entry into the Internet home improvement market, Tubatu was once favored by capital: in 2011, it received Jingwei China A round investment, and in 2014, it received B round investment in Jingwei China and Sequoia China. 2015 is called the "Year of the Outbreak of Internet Home Decoration". In this year, Tubatu, who stepped on the trend, completed the C round of financing with Jingwei Venture Capital , Sequoia Capital , and 58.com. He also signed Wang Han , Lei Jiayin , Tong Dawei and other stars as spokespersons. But this also made Tubatu pay the price of huge losses.For example, from 2015 to the first half of 2018, Tubatu invested a total advertising expense of more than 200 million yuan in three and a half years, but did not bring ideal performance. During this period, the company's net loss totaled more than 3 billion yuan.
(III)
10 companies have obtained listing approval
Domestic medical imaging leader Lianying Medical plans to raise 12.48 billion yuan
Last week, a total of 10 companies have obtained listing approval , of which 2 main board companies were approved for the first release , and 8 registration system companies have been registered and registered as effective . The total amount of funds planned by 10 companies reached 21.978 billion yuan. CITIC Securities won 3.5 of them. In terms of the motherboard of
, two companies, Yuanfei Pet and Zhiwei Intelligent, were approved for the first release.
Among them, Yuanfei Pet passed the meeting on May 12 this year, and the China Securities Regulatory Commission approved its public issuance of no more than 34.1 million new shares. Yuanfei Pet is mainly engaged in the research, development, production and sales of pet supplies and pet food. From 2018 to the first half of 2021, the company's operating income was RMB 435 million, RMB 515 million, RMB 608 million and RMB 479 million, respectively, and the net profit attributable to shareholders was RMB 62.8214 million, RMB 54.9115 million, RMB 83.198 million and RMB 56.8896 million, respectively. It plans to raise 409 million yuan, and the health care institution is Everbright Securities . (For details, please click: "Yuanfei Pet's overseas revenue accounts for 90% of it, and it has related transactions with China Pet Co., Ltd., and the disclosed data is very different" )
In terms of the Science and Technology Innovation Board, the registration of four companies, including Zhenhua Fengguang, Lianying Medical, Xuantai Pharmaceutical, and Xinke Mobile, have been effective.
Among them, Lianying Medical, the leading domestic medical imaging sub-sector, passed the first launch on April 15 this year. The company's main business is high-end medical imaging equipment. It is considered in the industry that it can challenge the three overseas giants GE Medical, Philips Medical and Siemens Medical. From 2019 to 2021, Lianying Medical's operating income was RMB 2.979 billion, RMB 5.761 billion and RMB 7.25 billion, respectively, and its net profit attributable to shareholders was RMB -73.5198 million, RMB 903 million and RMB 1.417 billion, respectively. Lianying Medical plans to raise 12.48 billion yuan in this IPO, which has not been seen in in the A-share market for a long time. The prospectus shows that after the full exercise of the over-allotment rights, Lianying Medical plans to issue 115 million shares, accounting for no less than 10% of the total share capital after issuance and no more than 13.71%. Based on this calculation, its issuance valuation is around 100 billion yuan. (For details, please click: "The leading medical imaging company Lianying Medical raises 10 billion yuan, and there is a gap between high-end products and overseas giants" )
In terms of the GEM, four companies, including Jiaman Clothing, Polygu New Materials, Xinde New Materials, and Weifeng Electronics, have been registered and effective.
, a mid-to-high-end children's clothing operator, passed the meeting on March 23 this year. The company owns two own children's clothing brands, Shuihaier and Fisiluting, two authorized brands, Xiabushi and Hajis . It also represents international first-line brands such as Armani and BOSS. From 2019 to 2021, Jiaman Clothing achieved operating income of 897 million yuan, 1.043 billion yuan and 1.214 billion yuan respectively; net profit attributable to shareholders was 89.4838 million yuan, 119 million yuan and 195 million yuan respectively. It plans to raise 521 million yuan, and its sponsor is Dongxing Securities. (Please click for details: "Jiaman Clothing was warned for browsing orders, and hundreds of stores were closed and 125 stores were raised for 100 million yuan to open" )
(IV)
13 companies will attend the meeting this week
2 Sichuan companies Baili Tianheng and Wovent Biotechnology will face the big test
This week, 13 companies will attend the meeting, including 1 main board, 1 Science and Technology Innovation Board, 9 GEM, and 2 Beijing Stock Exchange. CITIC Construction Investment participated in two of them. In terms of the motherboard of
, only one company, Yongshuntai, was launched for the first time this week.
Yongshuntai is the largest malt manufacturer in China. The company plans to raise 930 million yuan, and the sponsor is CICC. From 2018 to 2020 and the first half of 2021, Yongshuntai's operating income was RMB 2.432 billion, RMB 2.938 billion, RMB 2.826 billion and RMB 1.485 billion, RMB 161 million, RMB 144 million, RMB 135 million and RMB 129 million, respectively. Yongshuntai reminded that the company has the risk of a single product structure, small room for industry growth and intensified competition. During the reporting period, the proportion of barley malt to main business revenue was 94.08%, 96.45%, 96.74% and 96.16% respectively. Malt is mainly used for beer manufacturing . At present, the industry's growth space is mainly affected by the overall development of the beer industry.If beer consumption declines in the future and industry competition intensifies, it may lead to a decline in the revenue of the company's existing major products and a decline in gross profit margin, which will in turn have an adverse impact on the company's operating performance.
For the Science and Technology Innovation Board, only one company, Baili Tianheng, was launched for the first time this week.
Belli Tianheng is a modern biomedical enterprise integrating drug research and development, production and marketing. It has the full range of drug research, development and production capabilities including small molecule chemical drugs, large molecule biological drugs and antibody-conjugated drugs (ADC drugs). It plans to raise 1.422 billion yuan, and the sponsor is Anxin Securities . From 2019 to 2021, Baili Tianheng's operating income was 1.207 billion yuan, 1.013 billion yuan and 797 million yuan, respectively, and the net profit attributable to shareholders was 7.7309 million yuan, 37.9016 million yuan, and -99.9913 million yuan, respectively. Baili Tianheng reminded that the company has a high risk of marketing promotion costs. During the reporting period, the amount of the company's sales expenses was RMB 580 million, RMB 474 million and RMB 314 million, respectively, accounting for 48.07%, 46.79% and 39.36% of the operating income, respectively. In addition, the company has certain debt repayment risks. At the end of each period of the reporting period, the company's current ratio and quick ratio were both low, with the debt-to-asset ratio (merged) being 60.74%, 56.61%, and 65.12%, respectively. During the reporting period, the company's raw material base project Phase II, Duote production line construction project, R&D project and other funds have a large demand, and the implementation cycle is relatively long. The company's capital demand will further increase, and the company's development may face certain debt repayment risks.
In terms of the GEM, nine companies including Zhishang Technology, Dakowei, Weice Biologics, Wovent, Pulai, Jingwei Information, Amperelong, Liuchun Intelligence, and Guaibao Pet will be held in intensive first launches this week.
Among them, Wovent's main business is engaged in the research and development, production and sales of in vitro diagnostic instruments, reagents and consumables, and agency business for non-self-produced in vitro diagnostic products. It plans to raise 531 million yuan, and the sponsor is Guojin Securities . From 2019 to 2021, Wovente's operating income was 387 million yuan, 379 million yuan and 479 million yuan, respectively, and the net profit attributable to shareholders was 66.4894 million yuan, 53.2305 million yuan and 75.849 million yuan, respectively. Wavente reminded that the company has a risk of relatively concentrated sales areas. During the reporting period, the company's market sales revenue in Sichuan Province was RMB 319 million, RMB 269 million and RMB 324 million, respectively, accounting for 82.83%, 71.54% and 67.99% of its main business revenue, respectively. The sales area was relatively concentrated, mainly because the sales of agent products were mainly concentrated in Sichuan Province. If there are major adverse changes in regional policies in Sichuan Province in the future and customers' demand for issuers' products decline, it will have an adverse impact on the company's business activities.
Guaibao Pet is engaged in the research, development, production and sales of pet food, and mainly engages in multiple categories of pet food for pet dogs and cats. It plans to raise 600 million yuan, and its sponsor is Zhongtai Securities. From 2019 to 2021, Guaibao Pet's operating income was RMB 1.403 billion, RMB 2.013 billion and RMB 2.575 billion, respectively, and the net profit attributable to shareholders was RMB 4.1602 million, RMB 111 million and RMB 140 million, respectively. Guaibao pet reminds that the company has the risk of impairing inventory in . At the end of each period of the reporting period, the book value of the company's inventory was 285 million yuan, 395 million yuan and 583 million yuan, respectively, accounting for 38.05%, 48.03% and 48.02% of the current assets, respectively. The company's inventory balance may further increase. (Please click on the details: " Nicholas Tse endorsement and cooperation variety show floods the screen, how can Gubao pets solve the hidden worries of profit" )
(V)
11 new stocks started this week's subscription
Hongye Futures issue price is less than 2 yuan, and the subscription is only 930 yuan
According to the new stock issuance arrangement, there are 11 new stocks for temporarily this week. According to the sector, there are 3 companies on the Science and Technology Innovation Board, 1 company on the Beijing Stock Exchange, and 5 companies on the ChiNext. On the schedule of
, you can subscribe to Jiangbolong this Monday, Guangliwei, Kuaike Electronics, and Haitai New Energy this Tuesday, Hongye Futures, University of Technology Keya, Mengke Pharmaceutical, and Zhongwei Semiconductor this Wednesday, Meishi Technology and Zijian Electronics this Thursday, and DekeLi this Friday. The total amount of new shares to be issued this week is expected to be 11.527 billion yuan.
Jiang Bolong issuance date is July 25, and plans to publicly issue A shares 42 million shares, of which 6.72 million shares are issued online, issuance price is 55.67 yuan, issuance price and earnings ratio is 24.76 times, the subscription limit for a single account is 6,500 shares, and the subscription quantity is an integer multiple of 500 shares. issuance subscription requires a market value of 65,000 yuan in Shenzhen market. The company's net profit from 2019 to 2021 was RMB 128 million, RMB 276 million and RMB 1.013 billion, respectively, with the year-on-year changes of of 326.73%, 115.48%, and 266.73%.
Guangli Micro issuance date is July 26, and plans to issue 50 million shares of A shares publicly, of which 12 million shares are issued online, with an issue price of 58.00 yuan, and the issuance price-earnings ratio is 230.39 times. The subscription limit for a single account is 12,000 shares, and the subscription quantity is an integer multiple of 500 shares. The maximum subscription must be held with a market value of 12,000 yuan in Shenzhen. The company's net profit from 2019 to 2021 was RMB 19.3309 million, RMB 49.8745 million and RMB 63.7472 million, respectively, with year-on-year changes of 293.89%, 158.00%, and 27.82%.
Kuaike Electronics issuance date is July 26, and it plans to issue 16 million A shares publicly, of which 16 million shares are issued online, with an issue price of 34.84 yuan, and the issuance price-earnings ratio is 36.07 times. The subscription limit for a single account is 16,000 shares, and the subscription quantity is an integer multiple of 500 shares. The maximum subscription must be held with a market value of 160,000 yuan in Shenzhen. The company's net profit from 2019 to 2021 was RMB 41.4921 million, RMB 63.7266 million and RMB 64.851 million, respectively, with year-on-year changes of 33.78%, 53.59%, and 1.76%.
Haitai New Energy issuance date is July 26, and plans to issue 53.8219 million A-shares publicly, of which 37.6819 million shares were issued online, with an issue price of 9.05 yuan and an issuance price of 24.58 times. The company's net profit from 2019 to 2021 was 59.6894 million yuan, 62.0456 million yuan and 147 million yuan respectively.
Hongye Futures issuance date is July 27, and plans to issue 101 million A shares publicly, of which 30.233 million shares are issued online, with an issue price of 1.86 yuan, and the issuance price-earnings ratio is 23.90 times. The subscription limit for a single account is 30,000 shares, and the subscription quantity is an integer multiple of 500 shares. The subscription is only 930 yuan for one hand. The maximum subscription requires a market value of 300,000 yuan for the Shenzhen Stock Exchange. The company's net profit from 2019 to 2021 was RMB 21.2664 million, RMB 66.3225 million and RMB 80.2115 million, respectively, with year-on-year changes of -73.59%, 211.87%, and 20.94%.
Implementation date of Keya of the University of Technology is July 27, and plans to issue 30.135 million shares of A shares, of which 8.588 million shares will be issued online initially, with an estimated fundraising of 655 million yuan. The fundraising will mainly be invested in smart heating application platform upgrades and key product industrialization projects; R&D center construction projects; supplementary working capital projects; marketing and operation and maintenance service network system upgrade construction projects, etc. The company's net profit from 2019 to 2021 was RMB 63.3237 million, RMB 61.7269 million and RMB 86.0977 million, respectively, with year-on-year changes of 8.10%, -2.52%, and 39.48%.
Mengke Pharmaceutical issuance date is July 27, and plans to issue 130 million A shares publicly, of which 24.7 million shares were initially issued online, with an estimated fundraising of 1.365 billion yuan. The fundraising will mainly be invested in innovative drug research and development projects; supplementary working capital projects; marketing channel upgrades and academic promotion projects, etc. The company's net profit from 2019 to 2021 was -115 million yuan, -86.3272 million yuan and -226 million yuan, respectively, with year-on-year changes of 23.20%, 25.17%, and -162.11%.
issuance date is July 27, and plans to issue 63 million A shares publicly, of which 10.71 million shares will be issued online, with an initial issuance of 10.71 million shares, which is expected to raise 813 million yuan. The fundraising will mainly be invested in automotive-grade chip R&D projects; home appliances and industrial control MCU chip R&D and industrialization projects; Internet of Things SoC and analog chip R&D and industrialization projects; supplementary working capital, etc. The company's net profit from 2019 to 2021 was RMB 24.9914 million, RMB 93.69 million and RMB 785 million, respectively, with year-on-year changes of -22.78%, 274.89%, and 737.92%.
Meishi Technology issuance date is July 28, and plans to issue 25 million A shares publicly, of which 10 million shares will be issued online, with an initial issuance of 10 million shares, and is expected to raise 543 million yuan. The fundraising will mainly be invested in intelligent distributed industry upgrading and headquarters office center construction projects; intelligent distributed display control upgrade and transformation projects; marketing network construction projects; supplement working capital, etc. The company's net profit from 2019 to 2021 was RMB 56.2297 million, RMB 76.0839 million and RMB 96.809 million, respectively, with year-on-year changes of 33.16%, 35.31%, and 27.24%.
Zijian Electronics issuance date is July 28, and plans to issue 17.7008 million A shares, of which 5.0445 million shares will be issued online, with an estimated fundraising of 553 million yuan. The fundraising will mainly be invested in consumer lithium-ion battery expansion projects; supplement working capital; Zijian R&D center construction projects, etc. The company's net profit from 2019 to 2021 was RMB 63.7654 million, RMB 118 million and RMB 101 million, respectively, with year-on-year changes of 58.15%, 84.68%, and -14.48%.
Dekeli issuance date is July 29, and plans to issue 24.32 million A shares publicly, of which 6.931 million shares will be issued online, with an initial issuance of 6.931 million shares, and is expected to raise 1.128 billion yuan. The fundraising will mainly be invested in high-speed optical module product line expansion and upgrading construction projects; supplement working capital; platform-based R&D projects of optical transmission subsystems, etc. The company's net profit from 2019 to 2021 was RMB 46.6549 million, RMB 142 million and RMB 126 million, respectively, with year-on-year changes of 229.55%, 205.07%, and -11.16%.
Red Star News Comprehensive Report Editor Ren Zhijiang
Editor Yang Cheng
(Download Red Star News, report the information with prizes!)
